A detailed history of Ipg Investment Advisors LLC transactions in Cytom X Therapeutics, Inc. stock. As of the latest transaction made, Ipg Investment Advisors LLC holds 12,500 shares of CTMX stock, worth $13,625. This represents 0.0% of its overall portfolio holdings.

Number of Shares
12,500
Previous 12,500 -0.0%
Holding current value
$13,625
Previous $15.3 Million 3.28%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 12, 2024

BUY
$1.07 - $1.55 $13,375 - $19,375
12,500 New
12,500 $19.4 Million
Q2 2021

Aug 13, 2021

BUY
$6.33 - $9.91 $79,125 - $123,875
12,500 New
12,500 $79.1 Million

Others Institutions Holding CTMX

About CytomX Therapeutics, Inc.


  • Ticker CTMX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 65,950,200
  • Market Cap $71.9M
  • Description
  • CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical...
More about CTMX
Track This Portfolio

Track Ipg Investment Advisors LLC Portfolio

Follow Ipg Investment Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ipg Investment Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ipg Investment Advisors LLC with notifications on news.